financetom
Business
financetom
/
Business
/
Tata Power completes sale of its defence biz to Tata Advanced Systems
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tata Power completes sale of its defence biz to Tata Advanced Systems
Nov 2, 2020 4:39 AM

Tata Power on Monday said it has completed the sale of its defence business to Tata Advanced Systems. Tata Advanced Systems is a wholly-owned subsidiary of Tata Sons. ”The sale was completed as per a Scheme of Arrangement, which was approved by the National Company Law Tribunal at Mumbai and Hyderabad in December 2019 and March 2020, respectively,” Tata Power said in a regulatory filing. The company said it is expected to receive an enterprise value of Rs 1,076 crore as an upfront payment.

Balance consideration is subject to completion of achieving certain milestones specified in the agreements, the company added. Tata Power said the sale of defence business is part of the company’s ongoing strategic plan to monetise its non-core assets and reduce overall leverage.

”The sale proceeds will help the company to reduce leverage and increase focus in the core business areas like renewable generation, distribution and new service-led businesses which will bring greater value for our shareholders,” Praveer Sinha, CEO and Managing Director, Tata Power said. Strategic Engineering Division (SED) is a non-core defence electronics division of the company, engaged in business of indigenous design, development, production, integration, supply and life cycle support of mission-critical defence systems.

The key products include manufacturing and assembling missile launchers, electronic warfare, night vision systems and gun systems. SED has three dedicated manufacturing units — Bangalore Electronic City, Vemagal in Karnataka (under construction) and an SEZ near Bengaluru (under construction).

First Published:Nov 2, 2020 1:39 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ADM division expands recall to include additional animal feed products
ADM division expands recall to include additional animal feed products
Jun 10, 2024
June 10 (Reuters) - Global grain trader Archer-Daniels-Midland's ( ADM ) nutrition unit said on Monday it would expand the product recalls announced earlier this year due to elevated levels of magnesium, sodium, calcium, chloride and/or phosphorus. No illnesses have been reported to date, the company said. ...
AssetMark Financial Reports Higher Platform Assets for May
AssetMark Financial Reports Higher Platform Assets for May
Jun 10, 2024
05:22 PM EDT, 06/10/2024 (MT Newswires) -- AssetMark Financial Holdings ( AMK ) reported platform assets late Monday of $117.7 billion at the end of May, up 3.5% month-on-month and roughly 22% from a year earlier. Net flows were $611 million last month, down 12% from April and 4.1% year-over-year, the company said. ...
Advantage Energy to Pay $450 Million for Western Canadian Oil and Gas Assets; Plans Bought-Deal Offering, New Credit Line
Advantage Energy to Pay $450 Million for Western Canadian Oil and Gas Assets; Plans Bought-Deal Offering, New Credit Line
Jun 10, 2024
05:27 PM EDT, 06/10/2024 (MT Newswires) -- Advantage Energy ( AAVVF ) ,on Monday said it agreed to acquire oil and gas assets in the Charlie Lake and Montney fields in Western Canada from a private seller for $450 million and will pay, in part, for the purchase with a bought-deal offering of subscription receipts. The Western Canadian oil and...
Eli Lilly exec expects obesity pill data in April 2025
Eli Lilly exec expects obesity pill data in April 2025
Jun 10, 2024
June 10 (Reuters) - Data from Eli Lilly's ( LLY ) late stage trial on experimental obesity pill orforglipron is expected in April 2025, a top Eli Lilly ( LLY ) executive said on Monday. The pill is part of a class of drugs known as incretins designed to mimic the action of the GLP-1 hormone, which helps regulate blood...
Copyright 2023-2026 - www.financetom.com All Rights Reserved